Anthony J.Whall

Partner

London + 44.20.7039.5127

Anthony Whall focuses his practice on U.K. tax and advises on a wide range of U.K. corporate and international tax matters. His experience ranges from international and domestic U.K. corporate tax transaction work to the direct and indirect tax aspects of real estate transactions. Anthony also works with sponsors, private equity groups, management teams, alternative capital providers, and funds to structure their investments and exits in a tax-efficient manner. In addition, he has represented a number of Firm clients in defending investigations and assessments raised by H.M. Revenue & Customs and other tax authorities.

Anthony has significant experience advising on the structuring, negotiation, and financing of M&A and private equity transactions. Recent representations include advising J.F. Lehman and Company on the acquisitions of Aeronautical and GI Holding Limited and Sureclean Limited, General Electric on the sale of its Industrial Air and Gas Technologies business to Colfax Corporation, and Euronext on its $530 million cash offer to acquire LCH. Clearnet SA. His M&A and private equity tax practice extends to advising management on their investment, incentive, and exit arrangements. He advised the management of OfficeTeam on its sale to Better Capital and the management team in connection with the sale by Cinven of Amdipharm Mercury Limited to Concordia Healthcare Corp for approximately $3.5 billion.

Anthony also has notable experience in the taxation of real estate and property transactions and has advised British Land, CBRE Global Investors, CIT Group, Hansteen Holdings, LondonMetric Property, and Meyer Bergman on many acquisitions, disposals, and reorganizations.

Experience

  • True Capital acquires majority stake in SneakJones Day advised True Capital Ltd in the acquisition of a majority stake in D2C zero sugar, energy drink business, Sneak.
  • Avient acquires Magna ColoursJones Day advised Avient Corporation in the $48 million acquisition of Magna Colours Ltd., a market leader in sustainable, water-based inks technology for the textile screen printing industry.
  • ABM amends and extends existing $1.95 billion credit facilityJones Day represented ABM Industries Incorporated, a leading provider of facility solutions, in connection with an amendment and extension to its existing $1.95 billion credit facility with Bank of America, N.A., as administrative agent.
  • Victorian Plumbing Group completes largest to date IPO on London Stock Exchange’s AIM marketJones Day represented Victorian Plumbing Group plc, the UK’s leading online specialist bathroom brand and the second largest retailer of bathroom products in the UK, in connection with its £850 million IPO on the London Stock Exchange’s AIM market.
  • ThinCats’ institutional investors advised in £160 million investment by Wafra Capital PartnersJones Day advised BAE Systems Pensions Trustees Limited, ESO InvestCo VI S.à r.l. and Black Lion Limited, the existing institutional shareholders of ThinCats, in connection with a £160 million strategic investment by Wafra Capital Partners in ThinCats, a leading alternative finance provider to mid-sized UK SMEs.
  • M. Safra & Co. sells 30 Fenchurch Street (formerly known as One Plantation Place) to Brookfield Asset ManagementJones Day represented M. Safra & Co. in the family office's disposal of 30 Fenchurch Street (formerly known as One Plantation Place), one of the largest office developments in the City of London, to funds managed by Brookfield Asset Management.
  • Merchant banking firm provides $165 million acquisition financing to multinational software companyJones Day represented a merchant banking firm in connection with a $165 million senior secured credit facility supporting the acquisition of a multinational software company.
  • Wells Fargo provides acquisition and development facility for mixed-use development in LondonJones Day advised Wells Fargo Bank, National Association in connection with the acquisition and development facility relating to a mixed-use development in Covent Garden, London.
  • CBRE Global Investors disposes of Spanish logistics portfolio to BankinterJones Day advised CBRE Global Investors, on behalf of its value-add fund European Value Partners (EVP 2), and its joint venture partner Valfondo (a developer and manager of Montepino logistics assets in Spain) on the sale to Bankinter of a portfolio of 22 Spanish logistics assets, totaling 865,000 sqm, together with a development pipeline of a further 13 logistics assets.
  • Resilience Management sells Lux Global Label Asia Pte. Ltd. to CCL IndustriesJones Day advised Resilience Management, LLC in it sale of Lux Global Asia Pte. Ltd. to CCL Industries Inc.
  • TransDigm Group sells Technical Airborne Components to Searchlight Capital PartnersJones Day advised TransDigm Group Incorporated in the sale of Technical Airborne Components, a leading designer and manufacturer of rods and struts for the aerospace industry, to Searchlight Capital Partners.
  • PTTEP acquires 20% participating interest in Oman's Block 61 from BP for up to US$2.59 billionJones Day represented PTT Exploration and Production Public Company Limited ("PTTEP"), a national petroleum exploration and production company based in Thailand, in connection with its subsidiary PTTEP MENA Limited's acquisition of a 20% participating interest in Oman's Block 61, one of the largest gas developments in the Middle East, from BP Exploration (Epsilon) Limited ("bp").
  • Atlas Arteria establishes new capital structure for Warnow Tunnel in GermanyJones Day advised Atlas Arteria, a global owner, operator, and developer of toll roads, on a new approximately 29-year debt facility for its Warnow Tunnel in Germany as part of a capital restructuring.
  • Astellas returns rights to Eligard® in Europe, Middle East, CIS, and Asia to TolmarJones Day represented Astellas Pharma Europe Ltd. in connection with a series of transactions, including the sale of related assets, in which Astellas returned its in-licensing rights to Eligard® (leuprorelin acetate for injectable suspension), a treatment for advanced prostate cancer, sold by Astellas in Europe, the Middle East, the Commonwealth of Independent States (CIS) and Asia, to Tolmar International Limited.
  • NW1 sells £50.8 million UK last-mile portfolio to InfraRed fundJones Day advised NW1 Partners in its £50.8 million sale of an eight asset urban logistics portfolio to InfraRed Capital Partners Limited.
  • Pictet Alternative Advisers to acquire three Grade II listed office buildings in ManchesterJones Day represented Pictet Alternative Advisers SA in connection with the £119 million acquisition of three Grade II listed office buildings in Manchester, United Kingdom from Helical Plc and continues to act on the acquisition financing with Helaba and establishment of a joint venture with XLB Property.
  • OakNorth refinances Staycity GroupJones Day advised OakNorth Bank plc in connection with its refinancing of the Staycity Group, an Irish-owned pan European aparthotel business with 21 properties across the UK, France, Ireland, Italy, and Germany.
  • Koch Equity Development invests preferred equity in AIM listed Victoria plcJones Day advised Koch Equity Development LLC ("KED"), the acquisition and investment subsidiary of Koch Industries, Inc., on its investment into AIM listed Victoria plc ("Victoria"), a UK-based global designer, manufacturer, and distributor of flooring products.
  • Blackstone Real Estate Debt Strategies provides financing to Weerts Group for acquisition and development of warehouse in Bury St EdmundsJones Day represented Blackstone Real Estate Debt Strategies in connection with a senior secured facility provided to Weerts Group to finance the acquisition and development of an 870,000 sq ft warehouse at Suffolk Park in Bury St Edmunds.
  • L Brands announces partnership with Next PLC for Victoria's Secret UKJones Day represented L Brands, Inc. in its partnership with Next PLC for its company-owned Victoria's Secret business in the United Kingdom and Ireland.